A single injection of a new, experimental form of self-amplifying RNA prolonged hormone synthesis for many weeks, healing the heart in pigs.

Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA ...

Researchers are redesigning lipid nanoparticles to do more than shuttle mRNA into cells, with preclinical studies suggesting ...

GenScript announced the official opening of its first European mRNA production site in Delft, the Netherlands, marking a significant expansion of the company's global mRNA platform and reinforcing ...

Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...

Touchlight, in collaboration with New England Biolabs (NEB®), announces the launch of the EnClose™ Cell-free dbDNA™ Synthesis Kit, a new benchtop solution enabling rapid enzymatic production of ...

The blobfish, once considered the ugliest animal in the world, has since had quite the redemption arc. Years after it was ...

GenScript opens its first European mRNA production site in Delft, strengthens transatlantic biotechnology infrastructure: Delft, The Netherlands Saturday, March 14, 2026, 13:00 Hr ...

From infrastructure to pharmaceuticals, AI-driven material synthesis is the next step forward in scientific research, and U ...

Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent ...

A team from University of Toronto Engineering is the first to synthesize long noncoding RNA (lncRNA) outside the cell—a new approach to drug discovery that has already yielded some promising ...